Products for Research Use Only
RegisterLogin

JTE-607

CAT: 0498-bs-83047C-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0498-bs-83047C-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Background
JTE-607 inhibits inflammatory cytokine production in human peripheral blood mononuclear cells (PBMC’s) without causing immunosuppression: IC50’s = 11 nM (TNF-), 5.9 nM (IL-1), 8.8 nM (IL-6), 7.3 nM (IL-8), and 9.1 nM (IL-10) .1 It displayed efficacy in a mouse model of septic shock.2 JTE-607 also showed inhibitory activity against acute myelogenous leukemia cell lines.3,4 Recently, the mechanism of action of JTE-607 (a pro-drug, with the active species being the free acid) has been found to be inhibition of pre-messenger RNA endonuclease Cleavage and Polyadenylation Specificity Factor 3 (CPSF3) .5,6 This prevents release of newly synthesized mRNA’s resulting in read-through transcription and the formation of DNA-RNA hybrid R-loop structures. Transcripts down-regulated by JTE-607 were related to DNA damage-based phenotype
Conjugation
Unconjugated
Buffer
White solid
Storage Conditions
-20°C

Related Products

CatalogName
BIO0461SM-5mgAnti-human IL-13 (CNTO 607 Biosimilar)
BIO0461SM-1mgAnti-human IL-13 (CNTO 607 Biosimilar)
BIO0461SM-20mgAnti-human IL-13 (CNTO 607 Biosimilar)

Alternative Products

CatalogName
BA6011-50JTE-607
C01186-1gJTE-607 Dihydrochloride
530225JTE-607 HCl
5185/50JTE 607 dihydrochloride

Popular Products